This inventor holds 1 USPTO granted patent. Top assignee: Integrated Dna Technologies, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Nathan Delvaux: Innovator in CRISPR Technology
Introduction
Nathan Delvaux is an accomplished inventor based in Iowa City, IA. He has made significant contributions to the field of genetic engineering, particularly in the area of CRISPR technology. His innovative work has the potential to advance scientific research and therapeutic applications.
Latest Patents
Nathan Delvaux holds a patent titled "Methods and Compositions for Inhibition of CRISPR Re-Cleavage Events." This patent addresses critical challenges in the CRISPR gene-editing process, enhancing its efficiency and reliability. He has 1 patent to his name, showcasing his expertise and dedication to innovation.
Career Highlights
Delvaux is currently employed at Integrated DNA Technologies, Inc., a leading company in the field of DNA synthesis and genetic research. His role at the company allows him to work on cutting-edge projects that push the boundaries of genetic engineering.
Collaborations
[This section has been skipped due to space constraints.]
Conclusion
Nathan Delvaux is a notable inventor whose work in CRISPR technology is paving the way for future advancements in genetic research. His contributions are essential to the ongoing evolution of this transformative field.